Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-24-003078
Filing Date
2024-11-14
Accepted
2024-11-14 09:16:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 sadaveritionlarimar_sc13ga1.htm SC 13G/A 96069
  Complete submission text file 0000905148-24-003078.txt   97898
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88225 | Film No.: 241457686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE AMERICAN LANE GREENWICH CT 06831
Business Address ONE AMERICAN LANE GREENWICH CT 06831 203-742-7740
Verition Fund Management LLC (Filed by) CIK: 0001454027 (see all company filings)

EIN.: 262472334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A